日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

可溶性尿激酶型纤溶酶原激活物受体与多柔比星治疗乳腺癌患者的心脏毒性:一项前瞻性探索性研究

Chu, Jian; Tung, Lillian; Atallah, Issam; Wei, Changli; Cobleigh, Melody; Rao, Ruta; Feinstein, Steven B; Usha, Lydia; Banach, Kathrin; Reiser, Jochen; Okwuosa, Tochukwu M

Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study

更正:多柔比星治疗乳腺癌患者可溶性尿激酶型纤溶酶原激活物受体与心脏毒性:一项前瞻性探索性研究

Chu, Jian; Tung, Lillian; Atallah, Issam; Wei, Changli; Cobleigh, Melody; Rao, Ruta; Feinstein, Steven B; Usha, Lydia; Banach, Kathrin; Reiser, Jochen; Okwuosa, Tochukwu M

Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells

PX-12(1-甲基丙基-2-咪唑二硫化物)抑制硫氧还蛋白系统可阻止 TZM-bl 细胞中的 HIV-1 感染

Mathias Lundberg, Åse Mattsson, Kathrin Reiser, Arne Holmgren, Sophie Curbo

The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition

细胞硫氧还蛋白-1/硫氧还蛋白还原酶-1 驱动的氧化还原是 HIV-1 进入抑制的化疗靶点

Kathrin Reiser, Leen Mathys, Sophie Curbo, Christophe Pannecouque, Sam Noppen, Sandra Liekens, Lars Engman, Mathias Lundberg, Jan Balzarini, Anna Karlsson

Methodological aspects of ELISA analysis of thioredoxin 1 in human plasma and cerebrospinal fluid

人血浆和脑脊液中硫氧还蛋白 1 的 ELISA 分析方法

Mathias Lundberg, Sophie Curbo, Kathrin Reiser, Thomas Masterman, Sten Braesch-Andersen, Irene Areström, Niklas Ahlborg

Is trichloroacetic acid an insufficient sample quencher of redox reactions?

三氯乙酸是否不能充分猝灭氧化还原反应的样品?

Sophie Curbo, Kathrin Reiser, Anna-Klara Rundlöf, Anna Karlsson, Mathias Lundberg